College Student Dies After Using tirzepatide Weight-Loss Drug
A 19-year-old California college student died in her London dorm after taking tirzepatide, a GLP-1/GIP receptor agonist marketed for weight loss as Mounjaro and Zepbound; the incident comes amid rising use of GLP-1 weight-loss meds in the U.S. (about 15% have tried such medications) and ongoing safety discussions.